Mimedx (MDXG) Shares Outstanding (2010 - 2026)

Mimedx (MDXG) has 17 years of Shares Outstanding (Entity) data on file, last reported at $148.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 0.9% year-over-year to $148.9 million; the trailing twelve-month figure through Mar 2026 stood at $148.9 million (up 0.9% YoY), and the FY2025 full-year result was $148.1 million, up 0.79% from the prior year.
• Shares Outstanding (Entity) grew to $148.9 million in Q1 2026, from $148.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $148.9 million in Q1 2026 to a low of $113.5 million in Q1 2022.
• A 5-year average of $132.2 million and a median of $146.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) climbed 27.86% in 2024 and grew 0.05% in 2025, its largest moves.
• Tracing MDXG's Shares Outstanding (Entity) over 5 years: stood at $113.7 million in 2022, then increased by 2.45% to $116.5 million in 2023, then rose by 26.13% to $146.9 million in 2024, then gained by 0.79% to $148.1 million in 2025, then rose by 0.57% to $148.9 million in 2026.
• Business Quant data shows MDXG's Shares Outstanding (Entity) at $148.9 million in Q1 2026, $148.1 million in Q4 2025, and $148.1 million in Q3 2025.